Sagent Pharmaceuticals (SGNT) To Benefit From Obama's Executive Order - Jefferies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. TGT
2. EL
3. SPY
4. WMT
5. ADI
6. ROST
7. BILL
8. MRK
9. MRNA
10. COTY

November 1, 2011 7:11 AM EDT
Get Alerts SGNT Hot Sheet
Price: $21.76 --0%

Rating Summary:
    1 Buy, 9 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
President Obama executive order to help ease the nation's current drug shortage will benefit Sagent Pharmaceuticals (NASDAQ: SGNT), according to analysts at Jefferies.

"With several shortage products already pending FDA approval, and a new manufacturing facility awaiting FDA inspection, Sagent should benefit from any FDA efforts to accelerate shortage approvals," analyst Corey Davis said in a research report today.

The firm reiterated their Buy rating and $28 price target.

For more ratings news on Sagent Pharmaceuticals click here and for the rating history of Sagent Pharmaceuticals click here.

Shares of Sagent Pharmaceuticals closed at $25.55 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Jefferies & Co, Barack Obama